Carbogen Amcis has successfully completed a US FDA pre-approval inspection for a new high potency drug. for a US multinational. Dishman's managing director JR Vyas said: "Post this approval, we expect business of around $10m per annum from our existing customers."
Money Control
Wednesday, 5 October 2011
Carbogen Amcis completes inspection
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment